Nanomaterials, including single walled carbon nanotubes (SWCNT), are being developed for a variety of commercial products. However, toxicity of these new materials has not yet been identified due to limited information regarding the relationship between their unique physicochemical properties and potential toxicity. We reported recently that dispersed SWCNT (DSWCNT) exposure in mice caused a rapid and progressive interstitial lung fibrosis without a persistent inflammation. From these studies, it was hypothesized that DSWCNT, due to their exceptionally small size, can quickly penetrate the alveolar epithelial wall, enter the underlying tissue, and induce a "direct" fibrotic effect by interacting with cells at the site of particle accumulation to induce collagen deposition. The present study investigated the effects of in vitro DSWCNT exposure of human lung fibroblasts on proliferation and collagen production using cell multiplication (MTT), and Western blot techniques. DSWCNT were prepared using methods described previously in our laboratory. The results demonstrated that: 1) pulmonary exposure to DSWCNT (10 ug/mouse) did not cause significant lung injury; however, DSWCNT did penetrate into the interstitial lung tissue as analyzed by electron microscopy; 2) DSWCNT stimulated fibroblast cell growth in vitro at doses of 0.3-1 ug/ml; 3) DSWCNT also induced collagen production and collagenase (MMP9) activation in the treated fibroblasts. We also observed that the dispersion status or size of the SWCNT is a critical factor in determining fibrogenicity. These findings provide new insights into the mechanisms of SWCNT-induced lung fibrosis and may aid in developing models for risk assessment of these nanoparticles.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.